Lactulose Dosing for Constipation
For adults with chronic constipation, start lactulose at 10-20 g (15-30 mL or 1-2 packets) daily, which can be increased to a maximum of 40 g (60 mL or 2-4 packets) daily if needed, though lactulose should be reserved for patients who have failed fiber and over-the-counter laxatives and who do not experience significant bloating. 1, 2
Adult Dosing Algorithm
Initial Dosing
- Starting dose: 10-20 g (15-30 mL or 1-2 packets) once daily 1
- The FDA-approved dosing for constipation is 15 g daily as the recommended initial dose 1
- Can be taken as a single evening dose or divided into two doses with equivalent efficacy 3
Dose Titration
- Titrate based on symptom response and tolerability 1
- If inadequate response after initial trial, increase to 40 g (60 mL or 2-4 packets) daily 1
- The goal is to produce 2-3 soft stools daily 2
- Japanese studies suggest 26 g/day may be optimal, with 39 g/day showing increased diarrhea risk (9.7% incidence) 4
Clinical Positioning
Lactulose should be considered only after failure of first-line therapies (fiber and over-the-counter laxatives like polyethylene glycol), particularly in patients without significant baseline bloating or abdominal pain 1. The 2023 AGA-ACG guidelines give lactulose only a conditional recommendation with very low certainty of evidence, based on two outdated trials from over 40 years ago in elderly nursing home patients 1.
Pediatric Dosing
Age-Based Dosing
- Infants: 2.5-10 mL daily in divided doses 2
- Children <8 years: 1.99 ± 0.43 mL/kg/day 5
- Children 8 to <12 years: 1.26 ± 0.25 mL/kg/day 5
- Older children and adolescents: 40-90 mL total daily dose 2
Pediatric Considerations
- Start low and titrate to achieve 2-3 soft stools daily 2
- If diarrhea develops, reduce dose immediately; if it persists, discontinue lactulose 2
- Evidence suggests lactulose is less effective than polyethylene glycol or mineral oil for pediatric functional constipation 6
Important Clinical Caveats
Side Effects and Tolerability
- Bloating and flatulence are dose-dependent and very common, which significantly limits clinical use 1
- These side effects may be particularly problematic in patients with preexisting bloating or abdominal pain 1
- Most adverse effects occur during the first treatment period and improve with continued use 3
- Diarrhea risk increases at higher doses (>26 g/day) 4
Evidence Quality Issues
The evidence supporting lactulose is notably weak—the 2023 AGA-ACG guidelines rated the overall certainty of evidence as very low 1. The two supporting RCTs were conducted over 40 years ago in elderly nursing home patients with unclear diagnostic criteria for constipation 1. Despite this, lactulose did show a dramatic reduction in fecal impactions and need for enemas in the elderly population studied 1.
Special Populations
- Diabetes mellitus type 2 (non-insulin dependent): Lactulose use in mildly constipated patients may not increase blood sugar levels 1
- Pregnancy: Lactulose is the only osmotic laxative that has been studied in pregnancy 1
- Renal insufficiency: Unlike magnesium oxide, lactulose does not require dose adjustment in renal disease 1
Cost Considerations
Generic lactulose is generally low cost (<$50 per month), though some branded formulations may be expensive 1
Comparative Effectiveness
Polyethylene glycol (PEG) is preferred over lactulose as it has stronger evidence (strong recommendation vs. conditional recommendation) and better tolerability 1, 7. For patients requiring prescription therapy, secretagogues (linaclotide, plecanatide) and prucalopride have strong recommendations with better evidence quality 1, 7.